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This meeting of the President's Cancer Panel was designed to provide an overview of known and suspect causes of cancer and to indicate those
that might be considered avoidable. Two complex concepts are inherent in this charge: cause and avoidability. Risk factors for cancer are designated
as causal when the evidence from observational and laboratory research is judged sufficient in relation to criteria for causality; the extent to which
cancers of specific sites can be avoided is best estimated by the attributable risk statistic, which incorporates both the exposure pattern and the rel-
ative risk for the cancer-causing agent. A research agenda on avoidable causes of cancer should then address both the risks associated with the
agents that cause cancer and the pattern of exposure to the agents. Presentations at the meeting highlighted gaps in the evidence on the risks
associated with various known and potential causes of cancer and on the patterns of exposure across the diverse groups within the population. In
spite of these gaps, presenters emphasized that the evidence is already sufficient to justify intervention for many agents and that action need not be
delayed for the well-characterized causes of cancer. In addition to research recommendations offered by presenters for specific causal agents, the
scientific basis for cancer prevention might be generally strengthened by new research strategies directed at developing new tools for exposure
assessment, for investigating the risks of mixtures, and for population surveillance. - Environ Health Perspect 103(Suppl 8):307-311 (1995)
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Introduction
This conference sought to provide an
overview of known and suspect causes of
cancer and to indicate those that might be
considered avoidable. The presentations
covered the full array of environmental
agents, including such widely present expo-
sures as air pollution, water pollution,
infectious agents, and ionizing and nonion-
izing radiation. They focused more specifi-
cally on hormones and medications,
occupational exposures, and lifestyle-associ-
ated risk factors such as diet, tobacco, and
alcohol. Gender and ethnicity were consid-
ered as factors that may influence exposure
patterns and determine responses to envi-
ronmental agents. The emerging field of
cancer genetics was also covered; this field
brings the promise of a heightened under-
standing ofmechanisms ofcancer causation
and even the possibility ofidentifying per-
sons at risk from environmental exposures
on the basis ofgenetic susceptibility.
This paper was presented at the President's
Cancer Panel Conference on Avoidable Causes of
Cancer held 7-8 April 1994 in Bethesda, Maryland.
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These wide-ranging presentations point
to myriad opportunities for future research
and to ways that the new evidence can be
used for cancer prevention and control. This
paper considers the needs for new etiologic
information on avoidable causes ofcancer
and the most immediate opportunities for
research, highlighting key issues raised dur-
ing the meeting. The coverage is selective,
given the broad scope ofthe presentations.
A number ofgeneral themes are appar-
ent. First, there have been numerous suc-
cesses using both epidemiologic and
laboratory-based approaches to identify
avoidable causes of cancer-such histori-
cally significant examples as Percivall Potts'
finding ofscrotal cancer in chimney sweeps
based on astute observation, and identi-
fication ofsmoking as a cause oflung can-
cer based on straightforward application of
the case-control design. These and other
examples ofsuccesses involved exposures to
single agents or environments.
A second theme is that we have had less
success in investigating more complex
exposures, particularly those like diet that
are correlates oflifestyle choices. For such
exposures, the signal-to-noise ratio may be
low. Biomarkers ofexposure, dose, suscep-
tibility, and response may enhance the sen-
sitivity of epidemiologic studies. Large
study populations represent another solu-
tion to the signal-to-noise problem.
Several papers reflected on a third
theme-that population is not homoge-
nous by race, ethnicity, and gender, by
socioeconomic status, or bysusceptibility to
cancer-causing agents. In a broadly con-
ceived scheme of the causal pathway that
leads to cancer, primary determinants of
patterns ofenvironmental exposure include
race, ethnicity, gender, income, and educa-
tion (Figure 1). These sociodemographic
factors may increase both the likelihood of
exposure to cancer-causing agents and the
doses of these agents. To strengthen the
scientific basis for prevention, papers were
unanimous in indicating that research
must reflect the diversity ofthe population.
Finally, some ofour successes in identi-
fying avoidable causes of cancer have
shown that this identification is only a first
step in cancer control. Cigarette smoking
remains an exemplary challenge. Over 40
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Figure 1. Cancer risk reflects environmental exposures
and genetic susceptibility.
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evidence that cigarette smoking causes lung
cancer, approximately 25% ofadults in the
United States are smokers, and adolescents
continue to start smoking, even with
knowledge of the future risks ofsmoking-
caused disease. We have learned that
tobacco control requires a broad-based
approach that incorporates strategies for
education, strategies for assisting the indi-
vidual smoker to quit, and strategies to
change the social milieu in ways that foster
smoking prevention and cessation (1).
Causes and Attributable and
Preventable Risks
The phrase "Avoidable Causes of Cancer"
incorporates two complex concepts: that of
causality and that ofavoidability. The con-
cept ofcausality and the identification of
causal relationships have long engaged not
only philosophers but scientists involved in
both experimental and observational
research (2). More modern systems for
gauging evidence and determining causality
date to the Koch-Henle postulates. The
currently applied criteria for determining
the causality ofexposure-disease associa-
tions include the strength ofthe association
and its consistency among studies, the pres-
ence of a dose-response relationship of
agentwith disease, proper temporality ofthe
association, and coherence and plausibility
of the association with other biomedical
evidence. These criteria have proven effec-
tive for agents like cigarette smoking that
are powerful risk factors for disease (3).
They have not been so readily applied to
agents with weaker effects and, indeed,
they may be inappropriate for this purpose
(4,5). Even the application ofthese criteria
requires a subjective determination of
whether they have been met. Consequently,
some suspect causes ofcancer quickly have
become cloaked in controversy as ambigu-
ous evidence is interpreted as showing or
not showing a causal relationship.
In describing the burden ofdisease that
might be avoided, epidemiologists use a
quantity referred to as attributable risk (4).
Attributable risk indicates the burden of
disease that could be avoided ifexposure to
the agent of concern were fully prevented.
One form of attributable risk, population
attributable risk (PAR), describes the pro-
portion of disease in a population associ-
ated with exposure to an agent. The PAR
can be calculated as:
PAR= (RR- 1)(P)/I + (RR- 1)(P),
where RR is the relative risk ofthe disease,
comparing persons exposed to the agent
with the nonexposed, and P is the propor-
tion of the population exposed to the risk
factor. The PAR increases with both the
value ofRR and ofP. The equation shows
that a rare exposure associated with high
RR for those exposed may have little
impact on PAR for the population in gen-
eral. For example, an agent that increases
cancer risk 10-fold for a small segment of
the population-for example, 0.001%-
has a PAR of only 0.009%. This example
might represent a strong occupational
cause of disease affecting a group ofwork-
ers. By contrast, the PAR for an agent with
a RR of 1.10 and an exposure prevalence of
10% is 1%.
Attributable risk estimates should be
interpreted as representing the theoretical
maximum number of cases avoidable if
the exposure of concern could be fully
removed, i.e., P reduced to zero. In prac-
tice, however, it may not be feasible to pre-
vent exposure completely, and the number
ofcases preventable by intervention may be
only some fraction of the theoretical esti-
mate ofPAR. Moreover, interventions may
not be intended to eliminate exposures but
to reduce those exceeding a threshold level
of acceptability. Radon, for example, has
been estimated to cause about 14,000 lung
cancer deaths per year in the United States
(6,7). These cases could be avoided only if
levels of radon in residences were reduced
to the background level in outdoor air, an
unachievable goal. Lubin and Boice (8)
show that reducing the levels in homes hav-
ing concentrations above the guideline
value ofthe U.S. Environmental Protection
Agency (U.S. EPA) removes only one-third
ofthe total burden oflung cancer attribut-
able to radon. Larger gains can be made
only by reducing concentrations in homes
below the guideline value as well. By con-
trast, the entire burden of lung cancer
caused by cigarettes could be eliminated
with complete control ofsmoking.
Many cancers of current public health
concern are likely to have multiple causes.
For diseases caused by multiple agents, the
total burden of disease theoretically pre-
ventable may exceed the observed number
ofcases or 100% ifthere are synergistic pat-
terns ofjoint action as assessed on an addi-
tive scale. For example, radon and cigarette
smoking are synergistic in causing lung
cancer (9). Estimates of radon-attributable
lung cancer cases can be conceptualized as
to include those caused by radon in never
smokers, those caused by radon in smokers,
and those caused jointly by radon and
smoking in smokers. This subtlety of the
attributable risk statistic is not widely
appreciated and, for example, there is a
widespread misconception that the lung
cancer cases that might be caused by radon
include only the 10 to 15% not directly
attributed to smoking.
Although simplistic in its mathematical
formulation ofcomplex biologic phenome-
non, the PAR makes clear that cancer can
be avoided by either reducing RR or P. As
a basis for avoiding cancer, we must iden-
tify causal agents, those factors with RR
above unity for which the evidence war-
rants designation of the association as
causal. Cases of cancer can be avoided by
reducing the value of RR (e.g., through
reduction ofthe level ofexposure or by use
of a chemopreventive agent) and also by
reducing the value of P (e.g., by eliminat-
ing the exposure). The development of
markers ofsusceptibility may allow us to
partition the population into two groups,
those with increased or higher RR because
of susceptibility and those with lower RR
or no increased risk who are not suscepti-
ble (Figure 2). Preventive strategies would
then target those with increased risk on the
basis ofsusceptibility.
To date, epidemiologic and laboratory-
based research have successfully identified
many risk factors for cancer. There are
abundant opportunities for cancer control
using this evidence. However, the principal
risk factors for some of the most common
cancers (e.g., colon cancer and prostate
cancer) have yet to be identified, and some
of the identified risk factors cannot be
readily modified (e.g., reproductive history
and risk for breast and uterine cancer).









Figure 2. Partitioning of the total population with rela-
tive risk (RRT) and exposure prevalence (PT) into popu-
lations genetically susceptible (S) and nonsusceptible
(NS).
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new research methods bringing laboratory-
based approaches into the population con-
text, so-called molecular epidemiology,
offer stronger data in support of cancer
control initiatives.
The New Tools
A number of new research tools have the
promise ofdeepening our understanding of
the causes of cancer. These tools include
the rapidly advancing techniques of mod-
ern molecular and cellular biology, which
are already providing markers of genetic
susceptibility for some cancer sites, and
biomarkers of exposure and dose, which
can sharpen the characterization ofrisks in
population studies. This blending ofmark-
ers of susceptibility, exposure, dose, and
response into the population context has
been called molecular epidemiology.
The tools also include powerful new
study designs. Relative risks are anticipated
to be relatively modest for many potential
risk factors ofcurrent concern and quanti-
fication of the risks may be compromised
by exposure misclassification and confound-
ing. Large studies are needed to address such
risks; studies have now been conducted
that demonstrate the feasibility ofcollecting
information from large groups and then
following the subjects for disease incidence
and mortality. In the Nurses Health Study,
for example, information on risk factors was
obtained by mailed questionnaire on enroll-
ment from over 100,000 nurses who were
then followed actively and passively (10).
The subsequent collection ofdietary infor-
mation using a food frequency approach
makes this study a unique source of infor-
mation on diet and cancer. Nested design
approaches that involve sampling within
larger study populations have also been
developed (11). These designs facilitate the
informative application of more compli-
cated, invasive, or expensive approaches for
assessing exposures or outcomes.
New tools are also available for expo-
sure assessment (12,13). The conceptual
basis for exposure assessment has become
increasingly formalized and the concept of
exposure broadened to encompass the full
range of media through which exposure
occurs. Exposure assessment technology
suitable for epidemiologic research has now
been developed for many environmental
agents. For example, radon can be readily
measured in indoor air using relatively
inexpensive passive monitoring devices;
thousands of measurements will be made
in the case-control studies now in progress
throughout theworld (14).
Biomarkers are indicators ofexposure,
dose, outcome, or susceptibility measured
in biologic specimens (15,16). Such bio-
markers have the promise ofheightening
the validity of indicators used in cancer
research. For smoking and lung cancer, for
example, levels of cotinine, a nicotine
metabolite, provide an index ofimmediate
exposure, and levels ofsome carcinogens
and adducts reflecting their binding to
DNA can be measured (17). Epidemio-
logic investigations have also incorporated
genotyping for putative susceptibility genes.
The Score Card in 1994
The predominant avoidable causes ofcan-
cer fall under the broad groupings of
tobacco, alcohol, diet and nutrition, hor-
mones and medications, occupational
exposures, environmental exposures, radia-
tion, and infectious agents. Gender, ethnic-
ity, and environment are also factors, as are
genetic susceptibility and interaction of
genetic susceptibility with the environ-
ment. Table 1 summarizes my impression
of the status of the evidence in each of
these areas. I have arbitrarily graded on a
four-level scale-from 0 to +++-for the
evidence on both components ofthe PAR,
the relative risk, and the exposure preva-
lence (P). While some might dispute these
summary designations, the table provides a
perspective on the relative status of the
evidence for these factors.
Tobacco smoking is at the highest level
of understanding for both the RR and P.
The extensive epidemiologic research on
tobacco smoking and health provides a
rich database on the RRs for the many
cancer sites causally linked to tobacco
smoking (18,19). Patterns oftobacco smok-
ing are also amply documented through
diverse population surveys (19). The pop-
ulation burden of smoking-attributable
death is regularly tracked and reported; a
Table 1. The status of the evidence on selected risk
factors for cancer including understanding of the









Infectious agents + +
Special populations + +/0
Abbreviations: RR, relative risk; P, exposure prevalence.
software system has been developed for
this purpose (20).
By contrast, the burden ofcancer asso-
ciated with diet remains uncertain and
controversial, although diet was consid-
ered to account for a substantial propor-
tion of cancer cases (35%) in the 1981
report of Doll and Peto (21). Dr. Walter
Willett reaffirmed this view of the impor-
tance of diet and suggested that most of
the attributed cases could, in fact, be pre-
vented (23). However, there are abundant
hypotheses concerning diet and cancer
that reflect the myriad components of the
diet that might act to increase or decrease
cancer risk and there is still little coherence
among the RR estimates for any particular
nutrient for a specific cancer site. There
have been notable successes in identifying
agents in the diet that cause cancer, but
the most prominent examples reflect
exposures, such as aflatoxin, that have an
impact in developing countries.
Table 1 makes clear that a substantial
research agenda remains to be met if we
are to target resources optimally to prevent
avoidable cases of cancer. Research is still
needed to quantify the RRs associated
with the many potential causes of cancer.
We also need evidence from the full array
ofresearch approaches used to understand
the causes ofcancer in man: epidemiologic
studies, animal studies, and more basic
laboratory approaches.
In general, we know less about patterns
ofexposure to the many agents that cause
cancer. National and other surveys provide
information on smoking, alcohol, and diet,
although the dietary data may not be
sufficiently detailed for all dietary compo-
nents of potential interest with regard to
cancer. Less information is available on
exposure patterns for other broad groups of
causal agents (Table 1).
The score card is particularly poor for
research on risk to special populations.
Relative risk values among special popula-
tions can be expected to differ from those
ofwhite populations and to vary because of
patterns of exposure and gene-environ-
ment interactions. To date, this anticipated
heterogeneity remains largely unexplored.
Research Opportunities
and Approaches
An extensive research agenda directed at
cancer etiology is needed to complete the
many gaps in research pointed out in Table
1. In spite ofthese gaps, it is apparent that
the evidence is already sufficient to justify
intervention for many of the categories in
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Table 1 and that action need not be delayed
forwell-characterized causes ofcancer.
Recommendations were offered for
each of the broad groups of factors dis-
cussed here. In addition to the recommen-
dations made for specific causal agents, the
scientific basis for cancer prevention might
be generally strengthened by new research
strategies directed toward developing new
tools for exposure assessment and investi-
gating the risks of mixtures, and toward
population surveillance.
Any strategy to prevent the occurrence
of avoidable cases of cancer must reflect
population patterns of exposure to the
agents of concern. Surveys at the local,
regional, and national levels now provide
insight into exposure distributions for some
agents such as cigarette smoking. However,
more comprehensive information that char-
acterizes exposures in relation to potential
determinants ofsusceptibility and to gen-
der, ethnicity, and other sociodemographic
factors are needed to set priorities and to
develop appropriately targeted interven-
tions. Data on key risk factors should span
the diverse groups within the population
and provide a description ofexposure dis-
tributions as well as determinants ofexpo-
sure. Information on exposure distributions
might be used to direct interventions
toward those at the highest risk and toward
those exposures that might be most effec-
tively reduced. Persons at high risk on the
basis ofgenotype might be given the high-
est priority. A holistic approach toward
exposure assessment would also serve to
profile cancer risk more generally andwould
facilitate consideration ofcombined expo-
sures that maysynergistically increase risk.
Investigation ofthe health risks ofcom-
binations offactors has proved equally vex-
ing to scientists using epidemiologic
approaches and those using laboratory
approaches. Yet, many ofthe causes ofcan-
cer are complex mixtures, like diet and
nutrition in general, or tobacco smoking.
The combined effects ofthe multiple agents
that cause particular cancers have also chal-
lenged our investigative capabilities. Some
mixtures, like tobacco smoke, have been
considered as though they were a single
agent from the public health perspective,
and the findings ofepidemiologic research
on these mixtures have adequately served
the purpose ofcancer control. By contrast,
for some mixtures like diet, the effects of
individual components must be character-
ized for effective cancer control. Obser-
vational studies can be used to investigate
mixtures, but exposure misclassification and
limited statistical power may compromise
their findings. Large study populations are
one solution to these problems ofinvesti-
gating complex mixtures. However, there
may be inadequate opportunity for replica-
tion, and exposure misclassification and
numbers ofcancer cases may still limit the
power ofseeminglylarge studies.
Innovative approaches for investigating
the effects of complex mixtures have not
been forthcoming (23). Biomarkers may
improve exposure estimation and more
efficient designs may strengthen observa-
tional studies. Mixtures of presumed
chemopreventive agents can be assessed in
randomized trials and randomization
strategies can be used to permit assessment
of the effects of individual mixtures or
combinations of agents. Neither observa-
tional studies nor clinical trials alone will
be sufficient, and a stronger context for
interpreting the effects ofmixtures must be
found in heightened understanding ofthe
mechanisms by which the components of
mixtures work in concert to cause cancer.
Finally, I concur with Dr. Hoda
Anton-Culver, who recommends develop-
ing population-based approaches for sur-
veillance of risk factors for cancer (24).
Public health surveillance incorporates
ongoing, systematic data collection with
analysis and interpretation of the health
data (25). The data serve the purpose of
prevention and control, and surveillance
can support the iteration of intervention
and evaluation. To date, we have missed
the opportunity for surveillance of the
changing causes ofcancer afforded by pop-
ulation-based registries such as those in the
National Cancer Institute's Surveillance,
Epidemiology, and End Results (SEER)
Program. Such population-based cancer reg-
istries should be recognized as cohortstudies
ofdynamic populations. Supplementing
ongoing case ascertainment with informa-
tion on known and putative causes ofcan-
cer gained from samples of the covered
population would constitute a surveillance
system for tracking changes in risk factors
and associated changes in cancer occurrence.
Conclusions
Research on the etiology ofcancer has had
some notable successes and provides a
framework for implementing an agenda of
research and intervention for cancer con-
trol. However, research strategies to iden-
tify avoidable causes ofcancer continue to
be constrained by the methodologic
difficulties posed by the low signal-to-
noise ratio for many lifestyle-associated
risk factors and the complexity ofthe envi-
ronmental exposures of current concern,
many ofwhich are complex mixtures. The
emerging field of cancer genetics offers a
new set of approaches and promises a
heightened understanding ofmechanisms
ofcancer causation, and even the possibil-
ity of identifying those at risk from envi-
ronmental exposures on the basis ofgenetic
susceptibility. In addition to the recom-
mendations made for specific causal
agents, the scientific basis for cancer pre-
vention might be generally strengthened
by new research strategies directed at devel-
oping new tools for exposure assessment
and investigating the risks ofmixtures, as
well as at population surveillance.
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